Articles with "p53 mdm2" as a keyword



Working title: Molecular involvement of p53‐MDM2 interactome in gastrointestinal cancers

Sign Up to like & get
recommendations!
Published in 2024 at "Cell Biochemistry and Function"

DOI: 10.1002/cbf.4075

Abstract: The interaction between murine double minute 2 (MDM2) and p53, marked by transcriptional induction and feedback inhibition, orchestrates a functional loop dictating cellular fate. The functional loop comprising p53‐MDM2 axis is made up of an… read more here.

Keywords: mdm2 axis; p53 mdm2; p53; mdm2 interactome ... See more keywords

Targeting the p53-MDM2 pathway for neuroblastoma therapy: Rays of hope.

Sign Up to like & get
recommendations!
Published in 2020 at "Cancer letters"

DOI: 10.1016/j.canlet.2020.09.023

Abstract: Despite being the subject of extensive research and clinical trials, neuroblastoma remains a major therapeutic challenge in pediatric oncology. The p53 protein is a central safeguard that protects cells against genome instability and malignant transformation.… read more here.

Keywords: p53; p53 mdm2; mdm2 pathway; pathway neuroblastoma ... See more keywords
Photo from archive.org

TPGS-mediated one-pot synthesis, XRD structural analysis, antimicrobial evaluation and molecular docking of novel heterocycles as potential inhibitors of p53-MDM2 protein

Sign Up to like & get
recommendations!
Published in 2020 at "Journal of Molecular Structure"

DOI: 10.1016/j.molstruc.2019.127252

Abstract: Abstract Novel heterocyclic bioactive small molecules bearing thioether moiety, fluorine containing dihydro pyridine and dihydro pyran were synthesized and characterized using spectroscopic methods (FT-IR, 1H, 13C and 19F NMR), LC-MS and SC-XRD. The reaction conducted… read more here.

Keywords: tpgs mediated; mediated one; one pot; p53 mdm2 ... See more keywords

Free Energy Profile and Kinetics of Coupled Folding and Binding of the Intrinsically Disordered Protein p53 with MDM2

Sign Up to like & get
recommendations!
Published in 2020 at "Journal of chemical information and modeling"

DOI: 10.1021/acs.jcim.9b00920

Abstract: Intrinsically disordered proteins (IDPs) exert their functions by binding to partner proteins via a complex process that includes coupled folding and binding. Motivated by that inhibiting the binding of the IDP p53 to its partner… read more here.

Keywords: folding binding; coupled folding; process; p53 ... See more keywords

Discovery of Novel p53-MDM2 Inhibitor (RG7388)-Conjugated PlatinumIV Complexes as Potent Antitumor Agents.

Sign Up to like & get
recommendations!
Published in 2024 at "Journal of medicinal chemistry"

DOI: 10.1021/acs.jmedchem.4c00784

Abstract: While a number of p53-MDM2 inhibitors have progressed into clinical trials for the treatment of cancer, their progression has been hampered by a variety of problems, including acquired drug resistance, dose-dependent toxicity, and limited clinical… read more here.

Keywords: antitumor agents; p53 mdm2; p53; mdm2 inhibitor ... See more keywords

Discovery of Novel Drug-Conjugate Molecule ZM484 with Dual p53-MDM2 and TOP1 Inhibition for the Treatment of Colorectal Cancer.

Sign Up to like & get
recommendations!
Published in 2025 at "Journal of medicinal chemistry"

DOI: 10.1021/acs.jmedchem.5c01003

Abstract: The blocking interaction between p53 and its negative regulator MDM2 is an engaging therapeutic strategy for antitumor drug development, and there are several drug candidates of p53-MDM2 inhibitors in clinical trials. In the present study,… read more here.

Keywords: novel drug; treatment; p53 mdm2; drug ... See more keywords

α-Helix-Mimicking Sulfono-γ-AApeptide Inhibitors for p53–MDM2/MDMX Protein–Protein Interactions

Sign Up to like & get
recommendations!
Published in 2020 at "Journal of Medicinal Chemistry"

DOI: 10.1021/acs.jmedchem.9b00993

Abstract: The use of peptidomimetic scaffolds is a promising strategy for the inhibition of protein–protein interactions (PPIs). Herein, we demonstrate that sulfono-γ-AApeptides can be rationally designed to mimic the p53 α-helix and inhibit p53–MDM2 PPIs. The… read more here.

Keywords: protein; protein interactions; protein protein; sulfono aapeptides ... See more keywords
Photo from wikipedia

Angler Peptides: Macrocyclic Conjugates Inhibit p53:MDM2/X Interactions and Activate Apoptosis in Cancer Cells.

Sign Up to like & get
recommendations!
Published in 2021 at "ACS chemical biology"

DOI: 10.1021/acschembio.0c00988

Abstract: Peptides are being developed as targeted anticancer drugs to modulate cytosolic protein-protein interactions involved in cancer progression. However, their use as therapeutics is often limited by their low cell membrane permeation and/or inability to reach… read more here.

Keywords: cancer; cell; p53 mdm2; angler peptides ... See more keywords

Functionalized Double Strain-Promoted Stapled Peptides for Inhibiting the p53-MDM2 Interaction

Sign Up to like & get
recommendations!
Published in 2020 at "ACS Omega"

DOI: 10.1021/acsomega.9b03459

Abstract: The Sondheimer dialkyne reagent has previously been employed in strain-promoted double-click cycloadditions with bis-azide peptides to generate stapled peptide inhibitors of protein-protein interactions. The substituted variants of the Sondheimer dialkyne can be used to generate… read more here.

Keywords: sondheimer dialkyne; strain promoted; stapled peptide; p53 mdm2 ... See more keywords
Photo by nci from unsplash

Relevance of the p53–MDM2 axis to aging

Sign Up to like & get
recommendations!
Published in 2018 at "Cell Death and Differentiation"

DOI: 10.1038/cdd.2017.187

Abstract: In response to varying stress signals, the p53 tumor suppressor is able to promote repair, survival, or elimination of damaged cells – processes that have great relevance to organismal aging. Although the link between p53… read more here.

Keywords: p53; p53 mdm2; mdm2 axis; relevance p53 ... See more keywords

In silico identification of prospective p53-MDM2 inhibitors from ASINEX database using a comprehensive molecular modelling approach

Sign Up to like & get
recommendations!
Published in 2025 at "Scientific Reports"

DOI: 10.1038/s41598-025-10589-8

Abstract: Cancer cells have a higher evolutionary potential than normal cells, which commonly leads to medication resistance and a decrease in the efficacy of existing cancer treatments. As a result, discovering new therapeutic drugs is an… read more here.

Keywords: p53 mdm2; mdm2; asinex database; p53 ... See more keywords